| Code | 4605A | ||||||||||
| MA number | 09/0109/10-S | ||||||||||
| Product Form: | cps end 90x40 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 24.02.2010 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Emanera 20 mg_40 mg_cps end_02_2024.pdf
|
| SPC: |
SPC_Emanera 20 mg_40 mg_cps end_02_2024.pdf
|
| Safety feature | Yes |
| Data update: | 21.03.2018 |
